also of note is Admedus received approval to go to Phase 2 clinical trials for their HSV2 vaccine around Xmas last year. They expect interim results sometime this year.
Dr. Cullen at Duke is commencing mouse trials for a cure:
http://cullenlab.duhs.duke.edu/faq/
The HHMI vaccine is particularly interesting because it may confer a cure via the method by which the vaccine works and it also has applicability to HIV cures, which we all know are orders of magnitude higher priority than our little "inconvenience."